Steve Lianoglou Selected Research

Histocompatibility Antigens Class I

11/2019

Transposable element expression in tumors is associated with immune infiltration and increased antigenicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steve Lianoglou Research Topics

Disease

7	Neoplasms (Cancer) 01/2020 - 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 11/2022
1	Neuroinflammatory Diseases 01/2020
1	Central Nervous System Diseases (CNS Diseases) 01/2020
1	Demyelinating Diseases (Demyelinating Disease) 01/2020
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2020
1	Mucopolysaccharidosis II (Hunter Syndrome) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 11/2019
1	Inflammation (Inflammations) 11/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2018
1	Atrophy 01/2018
1	Pathologic Processes 11/2008

Drug/Important Bio-Agent (IBA)

3	LigandsIBA 01/2020 - 01/2017
2	atezolizumabIBA 12/2018 - 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	EnzymesIBA 01/2020
1	Iduronic Acid (Iduronate)IBA 01/2020
1	LipidsIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Peptides (Polypeptides)IBA 11/2019
1	DNA Transposable Elements (Element, IS)IBA 11/2019
1	Histocompatibility Antigens Class IIBA 11/2019
1	TESIBA 11/2019
1	AminopeptidasesIBA 12/2018
1	Deubiquitinating EnzymesIBA 01/2018
1	CollagenIBA 01/2018
1	Tamoxifen FDA LinkGeneric 01/2018
1	AntibodiesIBA 01/2018
1	Programmed Cell Death 1 ReceptorIBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2016
1	Oxygen (Dioxygen)IBA 11/2008

Therapy/Procedure

3	Therapeutics 11/2022 - 12/2018
2	Immunotherapy 11/2019 - 12/2018
1	Enzyme Therapy 01/2020